Abstract
In this study, we tested 137 Turkish children with cancer (51 with acute leukemia, 48 with lymphoma, 38 with solid tumors) while they were undergoing chemotherapy, and a control group of 45 for evidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections using the enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). The control group included children with other disease who had applied to the outpatient clinic during the study period and had no history of jaundice or transfusion. Sixty-five (47.4%) patients with cancer and 7 (20%) children in the control group were positive for hepatitis B surface antigen (HBsAg) (p < 0.01). HBV DNA was detected in 59 (43.1%) patients and in 9 (20%) controls (p < 0.01). HCV specific antibody (anti-HCV) was detected in 8 (5.8%) patients and in 1 (2.2%) control (p > 0.05). Eight patients (5.8%) had circulating HCV RNA, but none had in the control group (p = 0.09). Ten (13.9%) of the 72 patients who were negative for HBsAg had circulating HBV DNA, and 7 (5.4%) of the 129 patients who were negative for anti-HCV had circulating HCV RNA. We concluded that HBV and HCV infections are common among Turkish children with cancer. In countries where HBV infection is widespread among the general population as in Turkey, children with cancer are under greater risk for HBV infection.
Similar content being viewed by others
References
Gitnick G. Hepatitis infection in immunocompromised patients. Gastroenterology Clinics of North America 1994; 23: 515–522.
Snyder JD, Pickering LK. Hepatitis A through E. In: Behrman RE, Kligegmen RM, Arvin AM (eds), Nelson Textbook of Pediatrics. 15th edn. Philadelphia: WB Saunders Company, 1996: 909–913.
Dibenedetto SP, Ragusa R, Sciacce A, et al. Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. Eur J Pediatr 1994; 153: 271–275.
Brink NS, Chopra R, Perrons CJ, et al. Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: A clinical and virological study. Br J Haematology 1993; 83: 498–503.
Locasciulli A, Cavelletto D, Pontisso P, et al. Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 1993; 82: 2564–2567.
Fink FM, Höcker-Schulz S, Mor W, et al. Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients. Pediatrics 1993; 152: 490–492.
Rossetti F, Cesaro S, Pizzocchero P, Cadrobbi P, Guido M, Zanesco L. Chronic hepatit B surface antigen-negative hepatitis after treatment of malignancy. J Pediatrics 1992; 121: 39–43.
Monteleone PM, Andrzejewski C, Kelleher JF. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Am J Pediatric Hematology/Oncology 1994; 16: 309–313.
Locasciulli A, Gornati G, Tagger A, et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991; 78: 1619–1622.
Grosheida P, Van Damme P. Prevention and control of hepatitis B in the community. Viral Hepatitis Prevention Board, Communicable diseases series No. 1. Edegem: Jacqmain Ltd, 1996.
World Health Organization. IARC Monographs on the evaluation of carcinogenic risks to humans: Hepatitis viruses (Vol. 59). Geneva: 1994.
Julius C, Westpal RG. The safety of blood components and derivatives. Hematology/Oncology Clinics of North America 1992; 6: 1057–1077.
Arico M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84: 2919–2922.
Badur S. Viral hepatitis in Turkey. In: Kılıçturgay K (ed), Viral Hepatit ‘94’. İstanbul: Nobel Tıp Kitabevleri Ltd. Şti, 1994: 15–38 (in Turkish).
Ke-Qin Hu, Vierling JM. Molecular diagnostic techniques for viral hepatitis. Gastroenterology Clinics of North America 1994; 23: 479–498.
Coursaget P, Le Cann P, Leboulleux D, et al. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Letters 1991; 83: 35.
Wang JT, Wang TH, Sheu JT, et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991; 163: 397–381.
Pao CC, Yao DS, Lin CY, et al. Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. Am J Clin Pathol 1991; 95: 591–595.
Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722–724.
Quint WGV, Hejtink RA, Schirm J, et al. Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995; 33: 225–229.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kocabaş, E., Aksaray, N., Alhan, E. et al. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 13, 869–873 (1997). https://doi.org/10.1023/A:1007420725704
Issue Date:
DOI: https://doi.org/10.1023/A:1007420725704